We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
228 hedge funds and large institutions have $1.84B invested in Corcept Therapeutics in 2022 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 72 increasing their positions, 83 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
116% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 19
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
43% more call options, than puts
Call options by funds: $10.6M | Put options by funds: $7.43M
15% more capital invested
Capital invested by funds: $1.59B → $1.84B (+$244M)
10% more funds holding
Funds holding: 208 → 228 (+20)
7.02% more ownership
Funds ownership: 69.78% → 76.8% (+7%)
13% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 83
Holders
228
Holders Change
+20
Holders Change %
+9.62%
% of All Funds
3.6%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
41
Increased
72
Reduced
83
Closed
19
Calls
$10.6M
Puts
$7.43M
Net Calls
+$3.22M
Net Calls Change
-$8.07M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$15.4M |
| 2 |
SG Americas Securities
New York
|
+$9.11M |
| 3 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$8.3M |
| 4 |
BlackRock
New York
|
+$8.01M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$6.77M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$33.3M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$10.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.63M |
| 4 |
Renaissance Technologies
New York
|
-$5.38M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$4.29M |
